Bio-energetic response of the heart to dopamine following brain death-related reduced myocardial workload: A phosphorus-31 magnetic resonance spectroscopy study in the cat

Journal of Heart and Lung Transplantation

Volumn 18, Issue 12, 1999, Pages 1189-1197

  Bruinsma, George J Brandon Bravo ^a   Nederhoff, Marcel G J ^a   Van De Kolk, Cees W A ^a   De Groot, Mark C H ^a   Slootweg, Piet J ^b   Bredée, Johan J ^a   Ruigrok, Tom J C ^a   Van Echteld, Cees J A ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CREATINE PHOSPHATE; DOPAMINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN DEATH; CAT; CONTROLLED STUDY; HEART HEMODYNAMICS; HEART PRESERVATION; HEART TRANSPLANTATION; MALE; NONHUMAN; PRIORITY JOURNAL; WORKLOAD;

ADENOSINE TRIPHOSPHATE; ANIMALS; BRAIN DEATH; CATS; DOPAMINE; ENERGY METABOLISM; HEART; HEART TRANSPLANTATION; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MYOCARDIUM; PHOSPHOCREATINE; PHOSPHORUS RADIOISOTOPES;

EID: 0032756020     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(99)00089-3     Document Type: Article

References (28)

1. Novitzky D. Selection and management of cardiac allograft donors. Curr Opin Organ Transplant. 3:1998;51-61.
2. O'Connell J.B., Bourge R.C., Costanzo-Nordin M.R., et al. Cardiac transplantation recipient selection, donor procurement, and medical follow-up . Circulation. 86:1992;1061-1079.
3. Ballester M., Obrador D., Abadal L., et al. Dopamine treatment of locally procured donor hearts relevance on postoperative cardiac histology and function . Int J Cardiol. 22:1989;37-42.
4. Guerraty A., Wechsler A.S. Defining the limits of suitability of cardiac allografts. Ann Thorac Surg. 50:1990;1-2.
5. Tixier D., Matheis G., Buckberg G.D., Young H.H. Donor hearts with impaired hemodynamics. J Thorac Cardiovasc Surg. 102:1991;207-214.
6. Bittner HB, Chen EP, Milano CA, et al. Myocardial β-adrenergic receptor function and high-energy phosphates in brain death-related cardiac dysfunction. Circulation 1995;92(suppl II):II-472-478.
7. 31P NMR spectroscopy. J Surg Res. 55:1993;599-606.
8. Brandon Bravo Bruinsma G.J., Nederhoff M.G.J., te Boekhorst B.C.M., Bredée J.J., Ruigrok T.J.C., van Echteld C.J.A. Brain death-induced alterations in myocardial workload and high-energy phosphates a phosphorus 31 magnetic resonance spectroscopy study in the cat . J Heart Lung Transplant. 17:1998;984-990.
9. Brandon Bravo Bruinsma G.J., Nederhoff M.G.J., Geertman H.J., et al. Acute increase of myocardial workload, hemodynamic instability, and myocardial histological changes induced by brain death in the cat. J Surg Res. 68:1997;7-15.
10. 31P nuclear magnetic resonance analysis of metabolite concentrations in Langendorff-perfused rabbit hearts. Biophys J. 48:1985;803-813.
11. Galiñanes M., Hearse D.J. Brain death-induced impairment of cardiac contractile performance can be reversed by explantation and may not preclude the use of hearts for transplantation. Circ Res. 71:1992;1213-1219.
12. Cooper D.K.C., Novitzky D., Wicomb W.N. The pathophysiological effects of brain death on potential donor organs, with particular reference to the heart. Ann Roy Coll Surg Eng. 71:1989;261-266.
13. Novitzky D., Cooper D.K.C., Reichart B. Hemodynamic and metabolic responses to hormonal therapy in brain-dead potential organ donors. Transplantation. 43:1987;852-854.
14. Novitzky D., Rhodin J., Cooper D.K.C., Ye Y., Min K.-W., DeBault L. Ultrastructure changes associated with brain death in the human donor heart. Transpl Int. 10:1997;24-32.
15. Novitzky D.C., Cooper K.C., Rose A.G., et al. Early donor heart failure following transplantation from myocardial injury sustained during brain death. Clin Transplant. 1:1987;108-113.
16. Shivalkar B., Loon van J., Wieland W., et al. Variable effects of explosive or gradual increase of intracranial pressure on myocardial structure and function. Circulation. 87:1993;230-239.
17. Seiler C., Laske A., Gallino A., et al. Echocardiographic evaluation of left ventricular wall motion before and after heart transplantation. J Heart Lung Transplant. 11:1992;867-874.
18. Novitzky D., Cooper D.K.C., Morrell D., et al. Change from aerobic to anaerobic metabolism after brain death, and reversal following triiodothyronine therapy. Transplantation. 45:1988;32-36.
19. Goarin J.P., Cohen S., Riou B., et al. The effects of triiodothyronine on hemodynamic status and cardiac function in potential heart donors. Anesth Analg. 83:1996;41-47.
20. Pinelli G., Mertes P.M., Carteaux J.P., et al. Myocardial effects of experimental acute brain death evaluation by hemodynamic and biological studies . Ann Thorac Surg. 60:1995;1729-1734.
21. Zhang J., Duncker D.J., Xu Y., et al. Transmural bioenergetic responses of normal myocardium to high workstates. Am J Physiol. 268:1995;H1891-H1905.
22. 31P-nuclear magnetic resonance spectroscopy . Transplant Proc. 27:1995;1650-1651.
23. Herijgers P., Flameng W. The effect of brain death on cardiovascular function in rats. Part II. The cause of the in vivo hemodynamic changes. Cardiovasc Res. 38:1998;107-115.
24. Mertes P.M., Beck B., Jaboin Y., et al. In vivo monitoring of myocardial interstitial neuropeptide tyrosine release following brain death. Transplant Proc. 25:1993;167-168.
25. Zukowska-Grojec Z. Neuropeptide Y. A novel sympathetic stress hormone and more. Ann N Y Acad Sci. 771:1995;219-233.
26. Wang X., Han C.D., Fiscus R.R., et al. Hypotension- and endotoxin-induced alterations in calcitonin gene-related peptide modulation by dexamethasone . Circ Shock. 34:1991;217-223.
27. Arnalich F., Hernanz A., Jiménez M., et al. Relationship between circulating levels of calcitonin gene-related peptide, nitric oxide metabolites and hemodynamic changes in human septic shock. Regul Pept. 65:1996;115-121.
28. Ahluwalia A., Cellek S. Regulation of the cardiovascular system by non-adrenergic non-cholinergic nerves. Curr Opin Nephrol Hypertens. 6:1997;74-79.